Physician profile
Kristy Anne Fisher
NPI 1346703824
$15,056.23
in general payments reported to CMS, 2019-2025
21 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $201 · 2023: $389 · 2024: $2,201 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $4,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,641.12 |
| Travel and Lodging | $4,011.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $4,857.55 | 2025 | Prospera |
| Abbott Laboratories | $3,573.52 | 2024-2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $2,296.11 | 2024-2025 | Evoke |
| Spinal Simplicity, LLC | $1,343.37 | 2024-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $1,015.17 | 2025 | Intracept, General - Pain Management |
| Nevro Corp. | $334.45 | 2024 | Senza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $243.37 | 2021-2022 | |
| Bioventus LLC | $226.72 | 2023-2024 | Stimrouter Implantable Kit, Stimrouter Implantable Kit |
| Globus Medical, INC. | $218.89 | 2025 | Excelsius Gps, Senza |
| Averitas Pharma INC. | $217.07 | 2024-2025 | Qutenza |
| Almatica Pharma LLC | $164.73 | 2022-2023 | Sertraline Hcl, Loreev Xr |
| Mml US, INC. | $120.69 | 2023-2025 | Reactiv8 |
| Abbvie INC. | $100.63 | 2022-2023 | |
| Spr Therapeutics, INC | $92.12 | 2023-2025 | Sprint Pns System |
| Si-Bone, INC. | $87.69 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $33.79 | 2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $33.15 | 2024 | Kyphon Express II Kyphopak Tray |
| Teva Pharmaceuticals USA, INC. | $32.17 | 2023 | Austedo Xr |
| Alnylam Pharmaceuticals INC. | $25.46 | 2023 | Givlaari |
| Vanda Pharmaceuticals INC. | $20.83 | 2021 | |
| Alkermes, INC. | $18.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristy Fisher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.